Eligen B12™
Eligen B12™ is a once-daily oral non-prescription medical food, which normalises B12 levels without injection.
Ionis and Akcea launch Phase III trial to treat polyneuropathy
Ionis and Akcea have launched a Phase III clinical trial of AKCEA-TTR-L to treat polyneuropathy in patients with hereditary TTR (hATTR) amyloidosis. Credit: Ed Uthman via Flickr.
Learn more
Hover over the logos to learn more about the companies who made this project possible.
Close
-
Malvern Panalytical
Malvern Panalytical offers characterisation tools for molecular analysis and small...
About
Malvern Panalytical offers characterisation tools for molecular analysis and small drug discovery to help accelerate development for the pharmaceutical industry.
FollowMake an Enquiry
-
Noble Life Sciences
Noble Life Sciences is a contract research organisation (CRO) offering...
About
Noble Life Sciences is a contract research organisation (CRO) offering preclinical development solutions for drugs, vaccines and medical devices.
FollowMake an Enquiry
-
Emisphere Technologies
Emisphere Technologies designs unique intracellular drug delivery mechanisms and advanced...
About
Emisphere Technologies designs unique intracellular drug delivery mechanisms and advanced oral formulations for pharmaceutical developers.
FollowMake an Enquiry